Real-Life Use of 3 Direct-Acting Antiviral Regimen in a Large Cohort of Patients with Genotype-1b HCV Compensated Cirrhosis - Concepedia

Concepedia

Publication | Open Access

Real-Life Use of 3 Direct-Acting Antiviral Regimen in a Large Cohort of Patients with Genotype-1b HCV Compensated Cirrhosis

DOI Full Paper Access

17

Citations

0

References

2017

Year

Liana Gheorghe, Speranţa Iacob, Manuela Curescu, Ciprian Brisc, Cristina Cijevschi, Florin Alexandru Căruntu, C Stanciu, Iulia Simionov, Ioan Sporea, Cristian Gheorghe,

Journal of Gastrointestinal and Liver Diseases

Abstract

We report a high efficacy of the 3DAA regimen in a homogeneous compensated HCV genotype-1b liver cirrhosis population, in a real-life setting. Noninvasive fibrosis scores significantly improved at SVR12.